Lumos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 7, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7	15	-	-	-
Enterprise Value	11	22	-	-	-
Last Close Price	0.48	0.99	-	-	-
PE Ratio	16.80	34.84	-	-	-
PS Ratio	0.66	1.37	-	-	-
PB Ratio	1.02	2.11	-	-	-
P/TBV Ratio	0.94	2.11	-	-	-
P/OCF Ratio	2.05	4.59	-	-	-
EV/Sales Ratio	1.01	1.92	-	-	-
EV/EBITDA Ratio	5.48	10.36	-	-	-
EV/EBIT Ratio	16.27	30.73	-	-	-
Debt / Equity Ratio	1.15	1.15	3.23	2.49	1.15
Debt / EBITDA Ratio	3.94	3.94	3.93	1.58	2.39
Debt / FCF Ratio	-	-	-	3.14	2.26
Asset Turnover	0.55	0.55	0.71	0.76	-
Inventory Turnover	142.94	142.94	117.85	63.67	-
Quick Ratio	0.78	0.78	0.66	0.80	1.89
Current Ratio	0.79	0.79	0.66	0.81	1.92
Return on Equity (ROE)	9.45%	9.45%	10.25%	40.31%	-
Return on Assets (ROA)	2.15%	2.15%	1.91%	7.62%	-
Return on Capital (ROIC)	3.60%	3.60%	3.52%	10.86%	-
Return on Capital Employed (ROCE)	5.70%	5.70%	10.20%	35.60%	13.80%
Earnings Yield	6.42%	2.87%	-	-	-
FCF Yield	-64.21%	-28.72%	-	-	-
Payout Ratio	-	-	103.53%	58.70%	-
Buyback Yield / Dilution	-12.61%	-12.61%	-	28.63%	-

Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q